Rodrigo Madurga

1.3k total citations
37 papers, 872 citations indexed

About

Rodrigo Madurga is a scholar working on Biomaterials, Molecular Biology and Insect Science. According to data from OpenAlex, Rodrigo Madurga has authored 37 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Biomaterials, 12 papers in Molecular Biology and 9 papers in Insect Science. Recurrent topics in Rodrigo Madurga's work include Silk-based biomaterials and applications (14 papers), Silkworms and Sericulture Research (9 papers) and COVID-19 Clinical Research Studies (7 papers). Rodrigo Madurga is often cited by papers focused on Silk-based biomaterials and applications (14 papers), Silkworms and Sericulture Research (9 papers) and COVID-19 Clinical Research Studies (7 papers). Rodrigo Madurga collaborates with scholars based in Spain, France and United States. Rodrigo Madurga's co-authors include M. Elices, José Pérez‐Rigueiro, Gustavo V. Guinea, Gustavo R. Plaza, Ángel Ayuso‐Sacido, Noemí Garcia‐Romero, Alfonso M. Gañán‐Calvo, Josefa Carrión-Navarro, Núria Marí‐Buyé and Ana Ortiz de Méndivil and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Rodrigo Madurga

33 papers receiving 864 citations

Peers

Rodrigo Madurga
Jason S. Buhrman United States
David S. Bardenstein United States
Blake Lash United States
Archana V. Boopathy United States
Rodrigo A. Somoza United States
Michael J. Kratochvil United States
Roman Schoenauer Switzerland
Chong Wing Yung United States
Jason S. Buhrman United States
Rodrigo Madurga
Citations per year, relative to Rodrigo Madurga Rodrigo Madurga (= 1×) peers Jason S. Buhrman

Countries citing papers authored by Rodrigo Madurga

Since Specialization
Citations

This map shows the geographic impact of Rodrigo Madurga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodrigo Madurga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodrigo Madurga more than expected).

Fields of papers citing papers by Rodrigo Madurga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodrigo Madurga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodrigo Madurga. The network helps show where Rodrigo Madurga may publish in the future.

Co-authorship network of co-authors of Rodrigo Madurga

This figure shows the co-authorship network connecting the top 25 collaborators of Rodrigo Madurga. A scholar is included among the top collaborators of Rodrigo Madurga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodrigo Madurga. Rodrigo Madurga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez-Moreno, Juan Francisco, Guillermo de Velasco, Carlos Álvarez-Fernández, et al.. (2025). Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial. Clinical Cancer Research. 31(9). 1644–1656.
2.
Navarro, Paloma, Héctor Peinado, Elena Izquierdo, et al.. (2024). Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer. Journal of Clinical Investigation. 134(10). 15 indexed citations
3.
García-Donás, Jesús, Guillermo de Velasco, Rodrigo Madurga, et al.. (2023). Case–control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study. Clinical & Translational Oncology. 26(3). 732–738. 1 indexed citations
4.
Madurga, Rodrigo, Beatriz López‐Melgar, Roberto Martín‐Asenjo, et al.. (2022). Early Detection of Anthracycline- and Trastuzumab-Induced Cardiotoxicity: Value and Optimal Timing of Serum Biomarkers and Echocardiographic Parameters. ESC Heart Failure. 9(2). 1127–1137. 19 indexed citations
5.
Sevillano, Elena, et al.. (2022). Prognostic impact of fibroblast growth factor receptor (FGFR) genomic alterations and outcomes in patients with metastatic urothelial.. Journal of Clinical Oncology. 40(6_suppl). 537–537.
6.
Varona, José F., et al.. (2021). kinetics of anti-SARS-CoV-2 antibodies over time. Results of 10 month follow up in over 300 seropositive Health Care Workers. European Journal of Internal Medicine. 89. 97–103. 18 indexed citations
7.
Madurga, Rodrigo, et al.. (2021). Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing. Cancer Letters. 527. 66–79. 48 indexed citations
8.
Madurga, Rodrigo, et al.. (2021). Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19. BMC Emergency Medicine. 21(1). 89–89. 24 indexed citations
9.
Garcia‐Romero, Noemí, Josefa Carrión-Navarro, Rodrigo Madurga, et al.. (2021). Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma. Cells. 10(2). 202–202. 65 indexed citations
10.
Madurga, Rodrigo, et al.. (2021). Application of pelvic floor ultrasound during pregnancy to detect patients at risk of cesarean section due to failure of labor progression in a Spanish population. European Journal of Obstetrics & Gynecology and Reproductive Biology. 269. 102–107. 2 indexed citations
11.
Madurga, Rodrigo, et al.. (2021). Risk Score for Predicting In-Hospital Mortality in COVID-19 (RIM Score). Diagnostics. 11(4). 596–596. 21 indexed citations
12.
Garcia‐Romero, Noemí, Susana Esteban-Rubio, Rodrigo Madurga, et al.. (2020). Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion. Cells. 9(6). 1405–1405. 24 indexed citations
13.
Moreno, Irene, et al.. (2020). 1749P COVID-19 impact and predictive factors for mortality in cancer patients. Annals of Oncology. 31. S1021–S1021.
14.
Madurga, Rodrigo, Noemí Garcia‐Romero, Beatriz Jiménez, et al.. (2020). Normal tissue content impact on the GBM molecular classification. Briefings in Bioinformatics. 22(3). 5 indexed citations
15.
Moreno, Irene, et al.. (2020). 1760P COVID-19 severe pneumonia in cancer patients: Impact and predictive factors. Annals of Oncology. 31. S1024–S1024.
16.
Garcia‐Romero, Noemí, Rodrigo Madurga, Gorjana Rackov, et al.. (2019). Polyethylene glycol improves current methods for circulating extracellular vesicle-derived DNA isolation. Journal of Translational Medicine. 17(1). 75–75. 88 indexed citations
18.
Madurga, Rodrigo, Gustavo R. Plaza, Todd A. Blackledge, et al.. (2016). Material properties of evolutionary diverse spider silks described by variation in a single structural parameter. Scientific Reports. 6(1). 18991–18991. 42 indexed citations
19.
Jiang, Ping, Núria Marí‐Buyé, Rodrigo Madurga, et al.. (2014). Spider silk gut: Development and characterization of a novel strong spider silk fiber. Scientific Reports. 4(1). 7326–7326. 14 indexed citations
20.
Perea-Abarca, Belén, Christian Riekel, Gustavo V. Guinea, et al.. (2013). Identification and dynamics of polyglycine II nanocrystals in Argiope trifasciata flagelliform silk. Scientific Reports. 3(1). 3061–3061. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026